Inovio Pharmaceuticals Inc (INO)

9.55
0.04 0.42
NASDAQ : Health Care
Prev Close 9.59
Open 9.57
Day Low/High 9.38 / 9.69
52 Wk Low/High 4.50 / 11.69
Volume 885.65K
Avg Volume 1.26M
Exchange NASDAQ
Shares Outstanding 73.55M
Market Cap 694.30M
EPS -0.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

How to Cash in on the Fight Against the Zika Virus

How to Cash in on the Fight Against the Zika Virus

Where some see danger and upheaval, investors see opportunity. And the harrowing Zika virus is no different. Investors are jumping into stocks focused on detecting or wiping out the virus.

Inovio (INO) Stock Climbs, Launches Zika Vaccine Trial

Inovio (INO) Stock Climbs, Launches Zika Vaccine Trial

Inovio (INO) said on Monday that it initiated a clinical study of its preventive Zika vaccine in 160 subjects in Puerto Rico.

Inovio Launches Zika Vaccine Trial In Midst Of Puerto Rico Epidemic To Explore Early Signals Of Vaccine Efficacy

Inovio Launches Zika Vaccine Trial In Midst Of Puerto Rico Epidemic To Explore Early Signals Of Vaccine Efficacy

Inovio's second human Zika vaccine study, a placebo-controlled 160-subject trial, will test for safety, immune responses and initial evidence of efficacy

4 Stocks for Fighting Zika

4 Stocks for Fighting Zika

With a new Zika case now confirmed on Florida's East Coast, here's four stocks investors should consider as concerns about the virus reach an all-time high

Interesting INO Put And Call Options For October 21st

Interesting INO Put And Call Options For October 21st

Investors in Inovio Pharmaceuticals Inc. saw new options become available today, for the October 21st expiration.

Inovio Pharmaceuticals Expands Positive Phase I Ebola Vaccine Trial To Identify Most Optimal Immunization Regimen

Inovio Pharmaceuticals Expands Positive Phase I Ebola Vaccine Trial To Identify Most Optimal Immunization Regimen

Further enrollment to also build on safety database for Ebola and SynCon® immunotherapy technology, which has a favorable safety profile to date

Today's Weak On High Volume Stock: Inovio Pharmaceuticals (INO)

Today's Weak On High Volume Stock: Inovio Pharmaceuticals (INO)

Trade-Ideas LLC identified Inovio Pharmaceuticals (INO) as a weak on high relative volume candidate

Inovio (INO) Stock Slumps After Mixed Q2 Results

Inovio (INO) Stock Slumps After Mixed Q2 Results

Inovio (INO) reported a bigger-than-expected loss for the 2016 second quarter before Monday's market open.

Inovio Pharmaceuticals (INO) Is Today's Dead Cat Bounce Stock

Inovio Pharmaceuticals (INO) Is Today's Dead Cat Bounce Stock

Trade-Ideas LLC identified Inovio Pharmaceuticals (INO) as a "dead cat bounce" (down big yesterday but up big today) candidate

Inovio Pharmaceuticals Doses First Subject In Zika Vaccine Clinical Trial

Inovio Pharmaceuticals Doses First Subject In Zika Vaccine Clinical Trial

Phase I trial approved by US FDA and Health Canada

Inovio Deploys DNA-based Monoclonal Antibody Technology In Quest To Cure HIV

Inovio Deploys DNA-based Monoclonal Antibody Technology In Quest To Cure HIV

Funding for Potential Breakthrough Therapy is Part of Prestigious NIH/Delany Grant for Industry-Academic Collaboration

Inovio Pharmaceuticals (INO) Highlighted As Weak On High Volume

Inovio Pharmaceuticals (INO) Highlighted As Weak On High Volume

Trade-Ideas LLC identified Inovio Pharmaceuticals (INO) as a weak on high relative volume candidate

'Mad Money' Lightning Round: Be Patient on Alcoa

'Mad Money' Lightning Round: Be Patient on Alcoa

Cramer loves Popeyes Louisiana Kitchen but he can't recommend Harman International right now.

Jim Cramer's 'Mad Money' Recap: 'Brexit' Means Nothing to U.S. Stocks

Jim Cramer's 'Mad Money' Recap: 'Brexit' Means Nothing to U.S. Stocks

There's been so much news coverage about whether the United Kingdom will leave the European Union that it's making us numb, Cramer says.

Inovio Pharmaceuticals (INO) Optimistic on Zika/Ebola Vaccine Progress

Inovio Pharmaceuticals (INO) Optimistic on Zika/Ebola Vaccine Progress

Rising Biotech Company Inovio believes that its simultaneous vaccine efforts are well on their way to approval from the FDA.

First Week of INO February 2017 Options Trading

First Week of INO February 2017 Options Trading

Investors in Inovio Pharmaceuticals Inc. saw new options become available this week, for the February 2017 expiration.

Inovio Pharmaceuticals (INO) Is Today's Strong On High Volume Stock

Inovio Pharmaceuticals (INO) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Inovio Pharmaceuticals (INO) as a strong on high relative volume candidate

Strong On High Volume: Inovio Pharmaceuticals (INO)

Strong On High Volume: Inovio Pharmaceuticals (INO)

Trade-Ideas LLC identified Inovio Pharmaceuticals (INO) as a strong on high relative volume candidate

Inovio Pharmaceuticals Zika Vaccine Produces Robust Immune Responses In Non-Human Primates

Inovio Pharmaceuticals Zika Vaccine Produces Robust Immune Responses In Non-Human Primates

Inovio will conduct human studies later this year

Trade-Ideas: Inovio Pharmaceuticals (INO) Is Today's

Trade-Ideas: Inovio Pharmaceuticals (INO) Is Today's "Perilous Reversal" Stock

Trade-Ideas LLC identified Inovio Pharmaceuticals (INO) as a "perilous reversal" (up big yesterday but down big today) candidate